INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "(2S,5R)-5-(HYDROXYMETHYL)MORPHOLINE-2-CARBOXAMIDES AS AGONISTS OF SSTR4"

GENEVA, Feb. 10 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2024/071621) for "(2S,5R)-5-(HYDROXYMETHYL)MORPHOLINE-2-CARBOXAMIDES AS AGONISTS OF SSTR4" on Jul 31, 2024. With publication no. WO/2025/027049, the details related to the patent application was published on Feb 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HEHN, Joerg P. (Boehringer Ingelheim International GmbH, Global Patents, Binger Strasse 17355216 INGELHEIM AM RHEIN), GIOVANNINI, Riccardo (Boehringer Ingelheim International GmbH, Global Patents,...